Fundamental Valuation Report Insmed(INSM:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$33.73 (USD) 04/30/2021 Weighted Valuation$31.94 (USD) Overall RatingOvervalued by 5.3% Valuation Models Comparables: $24.58 (USD) (in order of …
Insmed (INSM:NAS) Fundamental Valuation Report Read more »
Read More
Fundamental Valuation Report Iovance Biotherapeutics(IOVA:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$31.44 (USD) 04/30/2021 Weighted Valuation$28.57 (USD) Overall RatingOvervalued by 9.1% Valuation Models Comparables: $26.70 (USD) (in order …
Iovance Biotherapeutics (IOVA:NAS) Fundamental Valuation Report Read more »
Read More
Fundamental Valuation Report Apellis Pharmaceuticals(APLS:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$44.76 (USD) 04/15/2021 Weighted Valuation$45.71 (USD) Overall RatingFairly valued to slightly Undervalued by 2.1% Valuation Models Comparables: $43.52 …
Apellis Pharmaceuticals (APLS:NAS) Fundamental Valuation Report Read more »
Read More
Fundamental Valuation Report Allogene Therapeutics(ALLO:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$32.86 (USD) 04/15/2021 Weighted Valuation$36.86 (USD) Overall RatingUndervalued by 12.2% Valuation Models Adjusted Book Value: $36.87 (USD) …
Allogene Therapeutics (ALLO:NAS) Fundamental Valuation Report Read more »
Read More
Fundamental Valuation Report Agios Pharmaceuticals(AGIO:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$53.36 (USD) 04/14/2021 Weighted Valuation$58.00 (USD) Overall RatingUndervalued by 8.7% Valuation Models Comparables: $74.03 (USD) Multiples: $64.54 (USD) …
Agios Pharmaceuticals (AGIO:NAS) Fundamental Valuation Report Read more »
Read More
Fundamental Valuation Report ACADIA Pharmaceuticals(ACAD:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$20.60 (USD) 04/13/2021 Weighted Valuation$31.40 (USD) Overall RatingUndervalued by 52.4% Valuation Models Comparables: $42.19 (USD) Adjusted Book …
ACADIA Pharmaceuticals (ACAD:NAS) Fundamental Valuation Report Read more »
Read More
Fundamental Valuation Report Nektar Therapeutics(NKTR:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$19.99 (USD) 03/26/2021 Weighted Valuation$24.92 (USD) Overall RatingUndervalued by 24.7% Valuation Models Comparables: $24.92 (USD) Valuation Methods …
Nektar Therapeutics (NKTR:NAS) Fundamental Valuation Report Read more »
Read More
Fundamental Valuation Report Intellia Therapeutics(NTLA:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$64.73 (USD) 03/26/2021 Weighted Valuation$49.50 (USD) Overall RatingOvervalued by 23.5% Valuation Models Comparables: $42.66 (USD) Valuation Methods …
Intellia Therapeutics (NTLA:NAS) Fundamental Valuation Report Read more »
Read MoreFundamental Valuation Report Apellis Pharmaceuticals(APLS:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$14.24 (USD) 27/02/2019 Weighted Valuation$37.26 (USD) Overall RatingUndervalued by 161.7% Valuation Models Analyst Consensus: $53.00 (USD) (in …
Apellis Pharmaceuticals (APLS:NAS) Fundamental Valuation Report Read more »
Read More